Pressure BioSciences, Inc. (PBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 10, 2025, 1:29 PM EDT
Pressure BioSciences Market Cap
Pressure BioSciences has a market cap or net worth of $21.48 thousand as of October 10, 2025. Its market cap has decreased by -99.75% in one year.
Market Cap
21.48K
Enterprise Value
29.20M
Revenue
1.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 31, 1996, Pressure BioSciences's market cap has decreased from 20.85M to 21.48K, a decrease of -99.90%. That is a compound annual growth rate of -21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 21.48K | -85.02% |
| Dec 31, 2024 | 143.39K | -98.15% |
| Dec 29, 2023 | 7.77M | -51.10% |
| Dec 30, 2022 | 15.89M | -13.44% |
| Dec 31, 2021 | 18.35M | 120.88% |
| Dec 31, 2020 | 8.31M | 177.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |